FIELD: health care.
SUBSTANCE: invention relates to health care, namely to the treatment of infectious diseases of the central nervous system (CNS) in children, and can be used in a wide clinical practice for the treatment of children with viral encephalitis. The method includes simultaneous intravenous drip administration of acyclovir at a dose of 10-15 mg/kg 3 times a day for 14-21 days, viferon rectally to children under 1 year of age at a dose of 150,000 I.U. 2 times a day for 14-21 days, from 1-7 years - 500,000 I.U. 2 times a day for 14-21 days, older than 7 years - 1 million I.U. 2 times a day for 14-21 days and vitamin D3 at a dose of 1000-3000 I.U. 1 time a day for 3-6 months.
EFFECT: present invention ensures high efficacy of treatment of viral encephalitis in children.
1 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING NEUROLOGICAL COMPLICATIONS OF VARICELLA IN CHILDREN | 2012 |
|
RU2533254C2 |
METHOD OF REHABILITATING NEUROLOGICAL DISORDERS IN CHILDREN IN CASE OF NEUROINFECTIONS | 2011 |
|
RU2482843C2 |
METHOD OF TREATING GENERALISED VASCULITIS ACCOMPANYING NEUROINFECTIONS IN CHILDREN | 2010 |
|
RU2444353C2 |
METHOD OF PREDICTING RISK OF NEUROLOGICAL COMPLICATIONS IN CASE OF CHICKEN POX IN CHILDREN | 2012 |
|
RU2481786C1 |
METHOD OF LEUKOENCEPHALITIS TREATMENT IN CHILDREN | 2007 |
|
RU2348411C2 |
METHOD FOR TREATMENT OF HERPES HEPATITIS | 2009 |
|
RU2441646C2 |
METHOD OF TREATING MULTIPLE SCLEROSIS IN CHILDREN | 2015 |
|
RU2596792C1 |
METHOD OF PREDICTION OF THE RISK OF DEVELOPMENT OF SYMPTOMATIC EPILEPSY IN NEUROINFECTIONS IN CHILDREN | 2017 |
|
RU2652967C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF INFECTIOUS ENCEPHALITIS IN CHILDREN | 2023 |
|
RU2824592C1 |
METHOD FOR EVALUATING THE SEVERITY OF CNS INFECTIOUS LESION IN CHILDREN | 2005 |
|
RU2295281C2 |
Authors
Dates
2022-12-26—Published
2022-02-09—Filed